Welcome to our dedicated page for Camden Natl SEC filings (Ticker: CAC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission filings for Camden National Corporation (NASDAQ: CAC), a Maine‑incorporated bank holding company. Through these filings, investors can review the company’s official disclosures about its commercial banking and wealth management activities, financial performance, capital position, and corporate governance.
Camden National Corporation files a range of documents with the SEC, including Form 8‑K current reports that announce material events. Recent 8‑K filings referenced in the available information cover topics such as quarterly earnings releases, dividend declarations, investor presentations, and board succession changes. These filings often include or reference press releases that detail net income, loan and deposit levels, asset quality metrics, and capital ratios, as well as information about quarterly cash dividends on the company’s common stock.
In addition to current reports, investors can use this filings page to locate the company’s annual reports on Form 10‑K and quarterly reports on Form 10‑Q, which provide more extensive discussions of Camden National Corporation’s business model, risk factors, regulatory environment, and financial statements. For a bank holding company, these periodic reports are key sources for understanding loan portfolios, deposit funding, capital adequacy, and non‑interest income streams, alongside the risk and capital disclosures that accompany them.
Users can also review filings related to dividend actions and board changes, as reflected in 8‑K items on dividend declarations and director retirement and succession. Where applicable, insider transaction reports on Form 4 can be consulted to see equity transactions by directors and officers.
Stock Titan’s platform enhances these regulatory documents with AI‑powered summaries that highlight the main points of lengthy filings, helping readers quickly identify key financial and governance information. Real‑time updates from the SEC’s EDGAR system, combined with simplified explanations of complex forms such as 10‑K, 10‑Q, 8‑K, and Form 4, make it easier to follow Camden National Corporation’s regulatory reporting and its implications for the CAC stock.
Camden National Corporation (CAC) – Form 4 insider filing
Director Raina Maxwell reported the receipt of 307 shares of CAC common stock on 20 June 2025. The shares were issued at $38.57 each under the company’s 2022 Equity and Incentive Plan in lieu of cash director fees.
Following the transaction, Maxwell’s aggregate direct holding increased to 1,759.601 shares. The filing was signed by Christopher G. Hutchinson under power of attorney and submitted on 23 June 2025.
No derivative securities were reported, and there were no dispositions. The transaction was coded “A” (acquisition) and is classified as a routine equity award to a non-employee director.
Camden National Corporation (CAC) – Form 4 insider transaction
Director Lawrence J. Sterrs disclosed the purchase of 204 common shares on 20-Jun-2025 at $38.57 per share. The acquisition was made under the company’s 2022 Equity & Incentive Plan as payment in lieu of cash director fees. After the transaction, Sterrs’ direct beneficial ownership rose to 14,351.598 shares.
No derivative securities were involved, no sales were reported, and the filing does not reference a Rule 10b5-1 trading plan. The dollar value of the purchase is approximately $7.9 thousand, representing a negligible portion of both daily trading volume and total shares outstanding; therefore, the filing is best interpreted as routine insider participation rather than a market-moving event.
On 06/20/2025, Camden National Corporation (CAC) director Craig N. Denekas acquired 454 shares of common stock at $38.57 per share, a transaction valued at roughly $17.5 thousand. The shares were issued under the company’s 2022 Equity and Incentive Plan in lieu of cash director fees, as indicated in the Form 4 filed on 06/23/2025.
After this routine equity-based compensation grant, Denekas’ direct holdings increased to 15,080 shares. The filing is coded “A” (acquisition) and does not reference a Rule 10b5-1 trading plan. No derivative securities were involved.
While stock compensation aligns director interests with shareholders, the small size and compensatory nature of this award mean the event is unlikely to affect Camden National’s valuation, liquidity, or governance profile in a material way.
Camden National Corporation (ticker: CAC) filed a Form 4 indicating that director Marie J. McCarthy acquired 388 shares of common stock on 06/20/2025. The shares were issued at an implicit value of $38.57 each under the company’s 2022 Equity and Incentive Plan as compensation in lieu of cash director fees. Following this routine grant, McCarthy’s direct beneficial ownership rises to 15,037.874 shares.
No shares were sold and no derivative securities were involved. The filing, signed by attorney-in-fact Christopher G. Hutchinson on 06/23/2025, contains no additional financial metrics, earnings data, or strategic announcements, making it a standard insider ownership update rather than a materially significant event.